Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CRSP - Vertex CRISPR gene therapy approved in EU for sickle cell disease beta-thalassemia

CRSP - Vertex CRISPR gene therapy approved in EU for sickle cell disease beta-thalassemia

CRISPR Therapeutics AG

2024-02-13 06:05:22 ET

Vertex Pharmaceuticals ( NASDAQ: VRTX ) has received conditional marketing authorization from the European Commission for its gene editing therapy, Casgevy (exagamglogene autotemcel), developed with CRISPR Therapeutics ( NASDAQ: CRSP )....

For further details see:

Vertex, CRISPR gene therapy approved in EU for sickle cell disease, beta-thalassemia
Stock Information
Company Name: CRISPR Therapeutics AG
Stock Symbol: CRSP
Market: NASDAQ
Website: crisprtx.com
Menu
CRSP CRSP Quote CRSP Short CRSP News CRSP Articles CRSP Message Board
Get CRSP Alerts

News, Short Squeeze, Breakout and More Instantly...